PharmaLundensis
0.05 SEK
-1.88 %
PHAL
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
PharmaLundensis is a research company. The company's main focus is on the treatment of serious lung diseases. Diseases that the company specializes in include chronic obstructive pulmonary disease (COPD), chronic bronchitis, and influenza-induced pulmonary failure. In addition to its main business, technical systems for handling drug emissions are developed. PharmaLundensis has its headquarters in Lund.
Read moreRevenue and EBIT-%
Revenue
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
Interim report Q1'26
General meeting '26
Interim report Q2'26